BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 30883183)

  • 21. New analytical methods focusing on polar metabolite analysis in mass spectrometry and NMR-based metabolomics.
    McCullagh J; Probert F
    Curr Opin Chem Biol; 2024 Jun; 80():102466. PubMed ID: 38772215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.
    Dunn WB; Broadhurst DI; Atherton HJ; Goodacre R; Griffin JL
    Chem Soc Rev; 2011 Jan; 40(1):387-426. PubMed ID: 20717559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass Spectrometry-Based Metabolomics.
    Kim YM; Heyman HM
    Methods Mol Biol; 2018; 1775():107-118. PubMed ID: 29876813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Liquid Chromatography-High Resolution Mass Spectrometry Metabolomics Method with High Specificity for Metabolite Identification Using All Ion Fragmentation Acquisition.
    Naz S; Gallart-Ayala H; Reinke SN; Mathon C; Blankley R; Chaleckis R; Wheelock CE
    Anal Chem; 2017 Aug; 89(15):7933-7942. PubMed ID: 28641411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiscale metabolomics techniques: Insights into neuroscience research.
    Wang X; Peng R; Zhao L
    Neurobiol Dis; 2024 Aug; 198():106541. PubMed ID: 38806132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.
    Yoshida M; Hatano N; Nishiumi S; Irino Y; Izumi Y; Takenawa T; Azuma T
    J Gastroenterol; 2012 Jan; 47(1):9-20. PubMed ID: 22041921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current metabolomics: technological advances.
    Putri SP; Yamamoto S; Tsugawa H; Fukusaki E
    J Biosci Bioeng; 2013 Jul; 116(1):9-16. PubMed ID: 23466298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample preparation methods for LC-MS-based global aqueous metabolite profiling.
    Beltran A; Samino S; Yanes O
    Methods Mol Biol; 2014; 1198():75-80. PubMed ID: 25270923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A liquid chromatography-mass spectrometry-based metabolomics strategy to explore plant metabolic diversity.
    Mori T; Rai A; Tsugawa H; Yamada Y; Saito K
    Methods Enzymol; 2023; 680():247-273. PubMed ID: 36710013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical identification strategies using liquid chromatography-photodiode array-solid-phase extraction-nuclear magnetic resonance/mass spectrometry.
    Moco S; Vervoort J
    Methods Mol Biol; 2012; 860():287-316. PubMed ID: 22351183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomics in Systems Biology.
    Baharum SN; Azizan KA
    Adv Exp Med Biol; 2018; 1102():51-68. PubMed ID: 30382568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of ion mobility-mass spectrometry for non-targeted metabolomics.
    Mairinger T; Causon TJ; Hann S
    Curr Opin Chem Biol; 2018 Feb; 42():9-15. PubMed ID: 29107931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics.
    Zhou Z; Luo M; Chen X; Yin Y; Xiong X; Wang R; Zhu ZJ
    Nat Commun; 2020 Aug; 11(1):4334. PubMed ID: 32859911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolome of canine and human saliva: a non-targeted metabolomics study.
    Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
    Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomic signature of brain cancer.
    Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
    Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics Toward Biomarker Discovery.
    Yin P; Xu G
    Methods Mol Biol; 2017; 1619():467-475. PubMed ID: 28674904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.